Patient Selection and TAVR vs. SAVR: Are We Ready for Low-Risk Patients? - Ron Waksman

↳ This is a section part of Moment: CRT 2017 : VALVE & STRUCTURAL - AORTIC - Transcatheter Aortic Valves

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$12.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Patient Selection and TAVR vs. SAVR: Are We Ready for Low-Risk Patients? - Ron Waksman at CRT 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$12.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Learning Objectives

Other Components in this Moment

Overview
Patient Selection and TAVR vs. SAVR: Are We Ready for Low-Risk Patients? - Ron Waksman
What Does the Future Hold for Alternative Access? - Vinayak Bapat
Expanding Indications for TAVR – What Should Be Next? - Michael Reardon
Second Generation TAVR Devices for Bicuspid Disease - Didier Tchetche
TAVR: Valve Thrombosis and Leaflet Thickening – 2016 Update - Raj Makkar
TAVR Durability, Reality and Expectations: A Careful Relook at the Data - Danny Dvir
Loading Simple Education